Goldman Sachs’ PE arm to acquire majority stake in Amsterdam-based Norgine, reportedly for €1.8B

Norgine, an Amsterdam pharmaceutical company, announced that Goldman Sachs Group Inc.’s PE arm has agreed to buy a majority stake in the company.

Read the full article at: siliconcanals.com